BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice

Stress can cause damage and atrophy of neurons in the hippocampus by deregulating the expression of neurotrophic factors that promote neuronal plasticity. The endocannabinoid system represents a physiological substrate involved in neuroprotection at both cellular and emotional levels. The lack of CB1 receptor alters neuronal plasticity and originates an anxiety‐like phenotype in mice. In the present study, CB1 knockout mice exhibited an augmented response to stress revealed by the increased despair behavior and corticosterone levels showed in the tail suspension test and decreased brain derived neurotrophic factor (BDNF) levels in the hippocampus. Interestingly, local administration of BDNF in the hippocampus reversed the increased despair behavior of CB1 knockout mice, confirming the crucial role played by BDNF on the emotional impairment of these mutants. The neurotrophic deficiency seems to be specific for BDNF as no differences were found in the levels of nerve growth factor and NT‐3, two additional neurotrophic factors. Moreover, BDNF impairment is not related to the activity of its specific tyrosine kinase receptor or the activity of the transcription factor cAMP responsive element binding. These results suggest that the lack of CB1 receptor originates an enhanced response to stress and deficiency in neuronal plasticity by decreasing BDNF levels in the hippocampus that lead to impairment in the responses to emotional disturbances.

[1]  F. Holsboer,et al.  Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice , 2008, The Pharmacogenomics Journal.

[2]  D. Cota,et al.  Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. , 2007, Endocrinology.

[3]  J Douglas Bremner,et al.  Stress and brain atrophy. , 2006, CNS & neurological disorders drug targets.

[4]  A. Mørk,et al.  Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat , 2006, Brain Research.

[5]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[6]  James P. Herman,et al.  Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  O. Valverde,et al.  Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  O. Valverde.  Participation of the cannabinoid system in the regulation of emotional-like behaviour. , 2005, Current pharmaceutical design.

[9]  B. Gorzalka,et al.  Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? , 2005, Behavioural pharmacology.

[10]  R. Mechoulam,et al.  Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice , 2005, Behavioural pharmacology.

[11]  John H. Morrison,et al.  Repeated stress and structural plasticity in the brain , 2005, Ageing Research Reviews.

[12]  K. Hsu,et al.  Behavioral Stress Modifies Hippocampal Synaptic Plasticity through Corticosterone-Induced Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Activation , 2004, The Journal of Neuroscience.

[13]  W. Cullinan,et al.  Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. , 2004, Endocrinology.

[14]  F. Rage,et al.  A single brain-derived neurotrophic factor injection modifies hypothalamo–pituitary–adrenocortical axis activity in adult male rats , 2004, Molecular and Cellular Neuroscience.

[15]  C. Ledent,et al.  The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice. , 2004, Life sciences.

[16]  K. Jin,et al.  Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. , 2004, Molecular pharmacology.

[17]  J. Manzanares,et al.  Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors , 2004, Neuropharmacology.

[18]  G. Marsicano,et al.  Involvement of brain‐derived neurotrophic factor in cannabinoid receptor‐dependent protection against excitotoxicity , 2004, The European journal of neuroscience.

[19]  M. Eder,et al.  CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.

[20]  S. Di,et al.  Nongenomic Glucocorticoid Inhibition via Endocannabinoid Release in the Hypothalamus: A Fast Feedback Mechanism , 2003, The Journal of Neuroscience.

[21]  E. Gould,et al.  Preclinical models: status of basic research in depression , 2002, Biological Psychiatry.

[22]  R. Duman,et al.  Pathophysiology of depression: the concept of synaptic plasticity , 2002, European Psychiatry.

[23]  I. Lucki,et al.  cAMP Response Element-Binding Protein Is Essential for the Upregulation of Brain-Derived Neurotrophic Factor Transcription, But Not the Behavioral or Endocrine Responses to Antidepressant Drugs , 2002, The Journal of Neuroscience.

[24]  M. Parmentier,et al.  Involvement of CB1 cannabinoid receptors in emotional behaviour , 2002, Psychopharmacology.

[25]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[26]  R. Sapolsky,et al.  The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death , 2000, Biological Psychiatry.

[27]  R. Sapolsky,et al.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.

[28]  K. Fuxe,et al.  Gluco‐ and mineralocorticoid receptor‐mediated regulation of neurotrophic factor gene expression in the dorsal hippocampus and the neocortex of the rat , 2000, The European journal of neuroscience.

[29]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[30]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[31]  E. Vreugdenhil,et al.  Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone , 1998, Brain Research.

[32]  A. Okragly,et al.  An Acid-Treatment Method for the Enhanced Detection of GDNF in Biological Samples , 1997, Experimental Neurology.

[33]  R. Kvetňanský,et al.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  O. Lindvall,et al.  Neurotrophins and brain insults , 1994, Trends in Neurosciences.

[35]  T. Bonner,et al.  Localization of cannabinoid receptor mRNA in rat brain , 1993, The Journal of comparative neurology.

[36]  Bruce S. McEwen,et al.  Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons , 1992, Brain Research.

[37]  R. Duman,et al.  Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment , 2006, Hippocampus.

[38]  P. Skudlarski,et al.  Early age-related cognitive impairment in mice lacking cannabinoid CB 1 receptors , 2005 .

[39]  E. Fridea,et al.  Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice , 2005 .

[40]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[41]  F. Rage,et al.  Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats , 2003, Hippocampus.

[42]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.

[43]  B. McEwen.  Stress and hippocampal plasticity. , 1999, Annual review of neuroscience.